Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, and Macroceutics, Inc., today...
Read more
Roche has announced that the phase III IMpower150 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that...
Read more
Chugai Pharmaceutical has announced that the primary endpoint has been met for the global phase III HAVEN 3 (NCT02847637) study...
Read more
Adocia a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, announced top-line results of...
Read more
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray...
Read more
Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced that it has commenced a...
Read more
Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada; hereinafter “Sumitomo Dainippon Pharma”) and Angelini S.p.A. announced...
Read more
Swedish Orphan Biovitrum AB (Sobi) has announced that the first patient has been randomised in the phase 3 study anaSTILLs,...
Read more
ABIVAX announced the enrolment of the first patient in the ABX464-101 proof-of-concept study of its lead product candidate ABX464 in...
Read more
Novartis announced that the EC approved Tasigna® (nilotinib) for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
